Modeling pancreatic cancer in mice for experimental therapeutics
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy that is
characterized by early metastasis, low resectability, high recurrence, and therapy resistance …
characterized by early metastasis, low resectability, high recurrence, and therapy resistance …
International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic …
DC Whitcomb, T Shimosegawa, ST Chari, CE Forsmark… - Pancreatology, 2018 - Elsevier
Background Chronic pancreatitis (CP) is a progressive inflammatory disorder currently
diagnosed by morphologic features. In contrast, an accurate diagnosis of Early CP is not …
diagnosed by morphologic features. In contrast, an accurate diagnosis of Early CP is not …
[HTML][HTML] Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis
X Yang, J Chen, J Wang, S Ma, W Feng, Z Wu, Y Guo… - Immunity, 2022 - cell.com
Lipoprotein disorder is a common feature of chronic pancreatitis (CP); however, the
relationship between lipoprotein disorder and pancreatic fibrotic environment is unclear …
relationship between lipoprotein disorder and pancreatic fibrotic environment is unclear …
Local and systemic expression of immunomodulatory factors in chronic pancreatitis
Inflammatory and fibrotic events that drive chronic pancreatitis (CP) are likely orchestrated
via signaling of soluble cytokines and chemokines systemically and within the pancreas …
via signaling of soluble cytokines and chemokines systemically and within the pancreas …
P2X7R blockade prevents NLRP3 inflammasome activation and pancreatic fibrosis in a mouse model of chronic pancreatitis
GX Zhang, MX Wang, W Nie, DW Liu, Y Zhang, HB Liu - Pancreas, 2017 - journals.lww.com
Objectives The aim of this study was to investigate the role of P2X7R (purinergic 2X7
receptor) and NLRP3 (NACHT, LRR, and PYD domains–containing protein 3) …
receptor) and NLRP3 (NACHT, LRR, and PYD domains–containing protein 3) …
Genetically induced vs. classical animal models of chronic pancreatitis: a critical comparison
S Klauss, S Schorn, S Teller, H Steenfadt… - The FASEB …, 2018 - Wiley Online Library
Chronic pancreatitis (CP) is an utmost complex disease that is pathogenetically linked to
pancreas‐intrinsic (eg, duct obstruction), environmental‐toxic (eg, alcohol, smoking), and …
pancreas‐intrinsic (eg, duct obstruction), environmental‐toxic (eg, alcohol, smoking), and …
Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer
N Jugniot, R Bam, EJ Meuillet, EC Unger… - Bioengineering & …, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is often associated with a poor prognosis due to
silent onset, resistance to therapies, and rapid spreading. Most patients are ineligible for …
silent onset, resistance to therapies, and rapid spreading. Most patients are ineligible for …
Cerulein-induced chronic pancreatitis in Swiss albino mice: An improved short-term model for pharmacological screening
There is a need for short-term, reliable and reproducible animal model of chronic
pancreatitis (CP) in small animals like mice. This study was aimed to establish the 9 …
pancreatitis (CP) in small animals like mice. This study was aimed to establish the 9 …
Inhibition of Rb phosphorylation leads to H2S-mediated inhibition of NF-kB in acute pancreatitis and associated lung injury in mice
V Sundar, R Tamizhselvi - Pancreatology, 2020 - Elsevier
Background Acute pancreatitis (AP), an inflammatory condition of pancreas, destructs the
exocrine cells by releasing various pro-inflammatory cytokines that activates the stellate …
exocrine cells by releasing various pro-inflammatory cytokines that activates the stellate …
Relevance of Carcinogen-Induced Preclinical Cancer Models
RN Sewduth, K Georgelou - Journal of Xenobiotics, 2024 - mdpi.com
Chemical agents can cause cancer in animals by damaging their DNA, mutating their genes,
and modifying their epigenetic signatures. Carcinogen-induced preclinical cancer models …
and modifying their epigenetic signatures. Carcinogen-induced preclinical cancer models …